Discontinued — last reported Q3 '20
Medtronic Accrued Contingent Liabilities remained flat by 0.0% to $200.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $200.00M to $200.00M. Over 4 years (FY 2021 to FY 2025), Accrued Contingent Liabilities shows relatively stable performance with a 0.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests rising legal or regulatory risk, whereas a decrease indicates the resolution of past uncertainties or lower litigation exposure.
These are estimated obligations arising from past events where the occurrence of a future event is uncertain or the amou...
Common in large banks; peers often disclose this within legal reserves or litigation accruals.
accrued_contingent_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $200.00M | $200.00M | $300.00M | $200.00M | $200.00M | $400.00M | $200.00M | $200.00M | $200.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | +0.0% | +50.0% | -33.3% | +0.0% | +100.0% | -50.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | -33.3% | +0.0% | -33.3% | +0.0% | +100.0% | -33.3% | +0.0% | +0.0% |